Featured Research

from universities, journals, and other organizations

Belly Fat May Affect Liver Function

Date:
June 12, 2008
Source:
University of Southern California
Summary:
A new stud suggests the release of lipids from abdominal fat, which drains directly to the liver, increases overnight, providing additional insight as to how abdominal fat is associated with type 2 diabetes risk. The findings suggest that the increase of lipids released overnight from abdominal fat may cause insulin resistance.

A study by the University of Southern California (USC) suggests the release of lipids from abdominal fat, which drains directly to the liver, increases overnight, providing additional insight as to how abdominal fat is associated with type 2 diabetes risk.

"It has been shown that people who store body fat in their abdomens are at greater risk to develop diabetes and other chronic illnesses, but why this happens has remained unclear," says Lisa Nicole Harrison, B.S., Master's candidate, at the Keck School of Medicine of USC and lead author on the study. "Our study found lipid release from abdominal fat was substantially elevated during the night, which may be a primary mechanism leading to insulin resistance, a strong risk factor for type 2 diabetes."

The observed lipids drain directly to the liver, a key center of glucose and insulin metabolism, where they may accumulate as triglyceride and cause dysregulation of these important metabolic processes, Harrison says. The results highlight the importance of abdominal obesity in the pathogenesis of type 2 diabetes.

"Further studies in this area should look at the cause of overnight elevation of abdominal fat release as well as clarifying the role this plays in the development of obesity and insulin resistance," suggests Harrison.

The results of the study were presented at an oral session Monday, June 9 at the American Diabetes Association 68th Scientific Sessions held in San Francisco. Authors of the study "Nocturnal Outpouring of FFA from Visceral Fat Depot." included Lisa N. Harrison, Maya Lottati, Cathryn M. Kolka, Isabel R. Hsu, Vahe Mooradian, Justin Dittmann, Edward Zuniga, Edgardo Paredes, Richard N. Berman.

The study was funded by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University of Southern California. "Belly Fat May Affect Liver Function." ScienceDaily. ScienceDaily, 12 June 2008. <www.sciencedaily.com/releases/2008/06/080610092734.htm>.
University of Southern California. (2008, June 12). Belly Fat May Affect Liver Function. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/06/080610092734.htm
University of Southern California. "Belly Fat May Affect Liver Function." ScienceDaily. www.sciencedaily.com/releases/2008/06/080610092734.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins